Biotherapy Services Limited - Accounts to registrar (filleted) - small 18.2
Biotherapy Services Limited - Accounts to registrar (filleted) - small 18.2
REGISTERED NUMBER: |
Financial Statements for the Year Ended 30 June 2021 |
for |
Biotherapy Services Limited |
Biotherapy Services Limited (Registered number: 08566712) |
Contents of the Financial Statements |
for the Year Ended 30 June 2021 |
Page |
Company Information | 1 |
Balance Sheet | 2 |
Notes to the Financial Statements | 4 |
Biotherapy Services Limited |
Company Information |
for the Year Ended 30 June 2021 |
DIRECTORS: |
SECRETARY: |
REGISTERED OFFICE: |
REGISTERED NUMBER: |
AUDITORS: |
Statutory Auditors |
5a Frascati Way |
Maidenhead |
Berkshire |
SL6 4UY |
Biotherapy Services Limited (Registered number: 08566712) |
Balance Sheet |
30 June 2021 |
30.6.21 | 30.6.20 |
Notes | £ | £ |
FIXED ASSETS |
Intangible assets | 4 |
Tangible assets | 5 |
CURRENT ASSETS |
Stocks |
Debtors | 6 |
Cash at bank |
CREDITORS |
Amounts falling due within one year | 7 | ( |
) | ( |
) |
NET CURRENT ASSETS |
TOTAL ASSETS LESS CURRENT LIABILITIES |
CREDITORS |
Amounts falling due after more than one year |
8 |
( |
) |
( |
) |
NET (LIABILITIES)/ASSETS | ( |
) |
CAPITAL AND RESERVES |
Called up share capital |
Share premium |
Retained earnings | ( |
) | ( |
) |
( |
) |
Biotherapy Services Limited (Registered number: 08566712) |
Balance Sheet - continued |
30 June 2021 |
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
The financial statements were approved by the Board of Directors and authorised for issue on |
Biotherapy Services Limited (Registered number: 08566712) |
Notes to the Financial Statements |
for the Year Ended 30 June 2021 |
1. | STATUTORY INFORMATION |
Biotherapy Services Limited is a |
The presentation currency of the financial statements is the Pound Sterling (£). |
2. | ACCOUNTING POLICIES |
Basis of preparing the financial statements |
These financial statements have been prepared in accordance with Financial Reporting Standard 102 |
"The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the |
provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have |
been prepared under the historical cost convention. |
The directors have considered the company's cashflows for the next 12 months.The directors remain confident about the company's future and are committed to its continued support. The directors consider the company retains sufficient working capital to continue trading for the foreseeable future. |
Accordingly, the directors have confirmed that it is appropriate to adopt the going concern basis for the preparation of these financial statements. |
Significant judgements and estimates |
In the application of the company's accounting policies the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. |
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. |
The company does not make significant estimates and assumptions concerning the future. |
Biotherapy Services Limited (Registered number: 08566712) |
Notes to the Financial Statements - continued |
for the Year Ended 30 June 2021 |
2. | ACCOUNTING POLICIES - continued |
Turnover |
Turnover is recognised on provision of services and goods sold at the fair value of the consideration received or receivable for services and goods provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates. |
Intangible assets |
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses. |
Tangible fixed assets |
Plant and machinery | - |
Fixtures and fittings | - |
Government grants |
The company received income from the Government Coronavirus Job Retention Scheme. Government grants are recognised in the income statement in the same period as the related expenditure. |
Stocks |
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition. |
Stocks held for distribution at no or nominal consideration are measured at the lower of replacement cost and cost, adjusted where applicable for any loss of service potential. |
At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss. |
Financial instruments |
Basic financial instruments are recognised at amortised cost using the effective interest method, except for investments in non-convertible preference and non-puttable preference and ordinary shares, which are measured at fair value, with changes recognised in profit or loss. Derivative financial instruments are initially recorded at cost and thereafter at fair value, with changes recognised in profit and loss. |
Biotherapy Services Limited (Registered number: 08566712) |
Notes to the Financial Statements - continued |
for the Year Ended 30 June 2021 |
2. | ACCOUNTING POLICIES - continued |
Taxation |
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
Current or deferred taxation assets and liabilities are not discounted. |
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
Deferred tax |
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. |
Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. |
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
Research and development |
Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated. |
Foreign currencies |
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result. |
Hire purchase and leasing commitments |
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter. |
The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability. |
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease. |
Pension costs and other post-retirement benefits |
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate. |
Biotherapy Services Limited (Registered number: 08566712) |
Notes to the Financial Statements - continued |
for the Year Ended 30 June 2021 |
3. | EMPLOYEES AND DIRECTORS |
The average number of employees during the year was |
4. | INTANGIBLE FIXED ASSETS |
Other |
intangible |
assets |
£ |
COST |
At 1 July 2020 |
and 30 June 2021 |
AMORTISATION |
At 1 July 2020 |
Charge for year |
At 30 June 2021 |
NET BOOK VALUE |
At 30 June 2021 |
At 30 June 2020 |
Biotherapy Services Limited (Registered number: 08566712) |
Notes to the Financial Statements - continued |
for the Year Ended 30 June 2021 |
5. | TANGIBLE FIXED ASSETS |
Plant and |
machinery |
etc |
£ |
COST |
At 1 July 2020 |
Additions |
Disposals | ( |
) |
At 30 June 2021 |
DEPRECIATION |
At 1 July 2020 |
Charge for year |
Eliminated on disposal | ( |
) |
At 30 June 2021 |
NET BOOK VALUE |
At 30 June 2021 |
At 30 June 2020 |
Fixed assets, included in the above, which are held under hire purchase contracts are as follows: |
Plant and |
machinery |
etc |
£ |
COST |
At 1 July 2020 |
and 30 June 2021 |
DEPRECIATION |
At 1 July 2020 |
Charge for year |
At 30 June 2021 |
NET BOOK VALUE |
At 30 June 2021 |
At 30 June 2020 |
Biotherapy Services Limited (Registered number: 08566712) |
Notes to the Financial Statements - continued |
for the Year Ended 30 June 2021 |
6. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
30.6.21 | 30.6.20 |
£ | £ |
Trade debtors |
Other debtors |
7. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
30.6.21 | 30.6.20 |
£ | £ |
Hire purchase contracts (see note 9) |
Trade creditors |
Taxation and social security |
Other creditors |
8. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |
30.6.21 | 30.6.20 |
£ | £ |
Hire purchase contracts (see note 9) |
Other creditors |
9. | LEASING AGREEMENTS |
Minimum lease payments fall due as follows: |
Hire purchase contracts |
30.6.21 | 30.6.20 |
£ | £ |
Net obligations repayable: |
Within one year |
Between one and five years |
Biotherapy Services Limited (Registered number: 08566712) |
Notes to the Financial Statements - continued |
for the Year Ended 30 June 2021 |
9. | LEASING AGREEMENTS - continued |
Non-cancellable operating | leases |
30.6.21 | 30.6.20 |
£ | £ |
Within one year |
Between one and five years |
10. | SECURED DEBTS |
The following secured debts are included within creditors: |
30.6.21 | 30.6.20 |
£ | £ |
Hire purchase contracts | 2,048 | 10,061 |
11. | DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006 |
The Report of the Auditors was unqualified. |
for and on behalf of |
12. | POST BALANCE SHEET EVENTS |
Post year end an investment of £1,500,000 has been received. This is sufficient based on the current run rate for the business to continue to trade for the next 12 months. |
13. | ULTIMATE CONTROLLING PARTY |
There is no ultimate controlling party. |